| Rosuvastatin-induced Generalized Drug Eruption |
|
Choi, Min Wha
(Department of Dermatology, Nowon Eulji Medical Center, Eulji University)
Lee, June Hyunkyung (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) Noh, Tai Kyung (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) Han, Tae Young (Department of Dermatology, Nowon Eulji Medical Center, Eulji University) |
| 1 | Rosenson RS. Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia. Expert Rev Cardiovasc Ther 2003;1:495-505 DOI |
| 2 | Oda T, Sawada Y, Yamaguchi T, Ohmori S, Haruyama S, Yoshioka M, et al. Drug Eruption Caused by Rosuvastatin. J Investig Allergol Clin Immunol 2017;27:140-141 DOI |
| 3 | Nardi G, Lhiaubet-Vallet V, Leandro-Garcia P, Miranda MA. Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct. Chem Res Toxicol 2011;24:1779-1785 DOI |
| 4 | Marguery M-C, Chouini-Lalanne N, Drugeon C, Gadroy A, Bayle P, Journe F, et al. UV-B phototoxic effects induced by atorvastatin. Arch Dermatol 2006;142:1065-1086 |
| 5 | Sommer M, Trautmann A, Stoevesandt J. Relief of photoallergy: atorvastatin replacing simvastatin. J Investig Allergol Clin Immunol 2015;25:138-140 |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
